Vanhuyse, Marie <br/><br/>
Do anti-angiogenic therapies prevent brain metastases in advanced renal cell carcinoma?  [electronic resource] 

 -  Bulletin du cancer  Dec 2012 
 - 100-6 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>1769-6917 
<br/><br/><label>Standard No.: </label>10.1684/bdc.2012.1672  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Alkaline Phosphatase--blood<br/>Angiogenesis Inhibitors--therapeutic use<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Benzenesulfonates--therapeutic use<br/>Bevacizumab<br/>Brain Neoplasms--blood<br/>Cancer Care Facilities<br/>Carcinoma, Renal Cell--blood<br/>Everolimus<br/>Female<br/>France<br/>Humans<br/>Indoles--therapeutic use<br/>Kidney Neoplasms--blood<br/>Male<br/>Middle Aged<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds<br/>Proportional Hazards Models<br/>Pyridines--therapeutic use<br/>Pyrroles--therapeutic use<br/>Retrospective Studies<br/>Risk Factors<br/>Sirolimus--analogs & derivatives<br/>Sorafenib<br/>Sunitinib<br/>Treatment Outcome